NFATC2 and B-cell chronic lymphocytic leukemia: demonstrated for the first time that in contrast to normal B-cell, malignant cells isolated from the peripheral blood of patients with CLL show nuclear/active NFAT1 even in the absence of in vitro stimulation; in parallel, NFκB and AP1 activation were also observed (60).